Galanthamine (hydrobromide)

[1]L J Scott, et al. Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60 (5) :1095-122.|[2]Marek Samochocki, et al. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. Pharmacol Exp Ther. 2003 Jun;305 (3) :1024-36.|[3]Acharya Balkrishna, et al. Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study. Molecules. 2019 Nov; 24 (22) : 4175.|[4]Balpreet Matharu, et al. Galantamine inhibits beta-amyloid aggregation and cytotoxicity. J Neurol Sci. 2009 May 15;280 (1-2) :49-58.|[5]Debby Van Dam, et al. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology (Berl) . 2005 Jun;180 (1) :177-90.|[6]Johan Monbaliu, et al. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Arzneimittelforschung. 2003;53 (7) :486-95.

Acta Pharmacol Sin. 2024 Jun;45 (6) :1160-1174.|Antioxidants (Basel) . 2022 Jun 23;11 (7) :1228.|Free Radic Biol Med. 2019 Dec;145:20-32.|Heliyon. 2024 Jun 3;10 (11) :e32322.|Antioxidants (Basel) . 2022 Feb 14;11 (2) :385.|Asian Pac J Trop Med. 2018, 8 (10) :500-512.|Biochem Pharmacol. 2020 Oct;180:114139.|bioRxiv. 2024 Apr 3:2023.06.02.542933.|bioRxiv. 2025 Sep 21.|J Chromatogr A. 2023 Oct 11:1708:464330.|J Pharmacol Sci. 2022 Apr;148 (4) :364-368.|Microorganisms. 2022 Oct 21;10 (10) :2089.|Nat Commun. 2023 Apr 17;14 (1) :2182.|PLoS Biol. 2024 Jun 27;22 (6) :e3002672.|Research Square Preprint. June 16th, 2022.